Mario Castro
University of Kansas School of Medicine 3901 Rainbow Blvd. Kansas City, KS 66160, USA · Washington University of St. Louis · University of Kansas
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mario Castro as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:38 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03953300 · Benralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsAstraZeneca · active not recruiting · Asthma · principal investigator
- Ph2NCT01825122 · Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow ObstructionInvion, Inc. · completed · Smoking Cessation · principal investigator
- N/ANCT01606826 · Severe Asthma Research ProgramMilton S. Hershey Medical Center · completed · Asthma · principal investigator
- N/ANCT01537133 · Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid TreatmentMilton S. Hershey Medical Center · completed · Asthma, Atopy · principal investigator
- Ph3NCT01248065 · Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in AsthmaMilton S. Hershey Medical Center · completed · Asthma · principal investigator
- N/ANCT01185275 · A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)Washington University School of Medicine · completed · Asthma · principal investigator
- Ph3NCT00565266 · Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)Milton S. Hershey Medical Center · completed · Asthma · principal investigator
- Ph3NCT00495157 · Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)Milton S. Hershey Medical Center · completed · Asthma · principal investigator
- Ph3NCT00318708 · Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)Milton S. Hershey Medical Center · completed · Asthma · principal investigator
- N/ANCT00217854 · Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial HyperreactivityWashington University School of Medicine · completed · Asthma · study chair
- Ph3NCT00200967 · Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)Milton S. Hershey Medical Center · completed · Asthma · principal investigator
- Ph3NCT00000577 · Asthma Clinical Research Network (ACRN)Milton S. Hershey Medical Center · withdrawn · Asthma, Lung Diseases · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Frontiers Clinical and Translational Science Institute at the University of KansasUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · fiscal years 2019 to 2026 · $3,688,094 awarded in 2026Same name and institution; not confirmed by an ID
- University of Kansas' Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE) Clinical CenterUG1HL139119 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · fiscal years 2017 to 2022 · $345,366 awarded in 2022Same name and institution; not confirmed by an ID
- Washington University K12 Program in T4 Implementation ResearchK12HL137942 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 2017 to 2018 · $594,513 awarded in 2018Same name and institution; not confirmed by an ID
- Severe Asthma Research Program (SARP)-Washington UniversityU10HL109257 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 2011 to 2016 · $641,924 awarded in 2016Same name and institution; not confirmed by an ID
- Human Subjects and Data Analysis CoreU19AI070489 · NIAID · WASHINGTON UNIVERSITY · fiscal years 2006 to 2015 · $408,044 awarded in 2015Same name and institution; not confirmed by an ID
- Washington University AsthmaNetU10HL098098 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 2009 to 2015 · $322,367 awarded in 2015Same name and institution; not confirmed by an ID
- Determinants of Asthma Following RSV Bronchiolitis in Early LifeR01HL092486 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 2009 to 2012 · $722,078 awarded in 2012Same name and institution; not confirmed by an ID
- SEVERE ASTHMA RESEARCH PROGRAM (SARPII) IMAGING CORER01HL091762 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 2008 to 2011 · $372,674 awarded in 2011Same name and institution; not confirmed by an ID
- AIRWAY REMODELING IN SEVERE ASTHMAM01RR000036 · NCRR · WASHINGTON UNIVERSITY · fiscal years 1996 to 2007 · $3,659 awarded in 2007Same name and institution; not confirmed by an ID
- Asthma Clinical Research Network-Washington UniversityU10HL074208 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 2003 to 2007 · $260,893 awarded in 2007Grant number is on one of their registry trials
- CONTROLLING ASTHMA IN AMER. CITIES PROJECT - PHASE II INTERVENTION IMPLEMENU59EH723263 · NCEH · ST. LOUIS REGIONAL ASTHMA CONSORTIUM · fiscal years 2003 to 2007 · $830,328 awarded in 2007Same name and institution; not confirmed by an ID
- Genetic, Biologic, & Immunologic Determinants of AsthmaR01HL061895 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 1998 to 2006 · $373,511 awarded in 2006Same name and institution; not confirmed by an ID
- Airway Remodeling in Severe AsthmaR01HL069149 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 2001 to 2005 · $478,290 awarded in 2005Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Clinical Coordinating Center for the Severe Asthma Research Program (SARP)U10HL109086 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI David T. Mauger · fiscal years 2011 to 2017Named on NCT01606826
- Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet)U10HL098115 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI David T. Mauger · fiscal years 2009 to 2015Named on NCT01537133, NCT01248065
- Asthma Clinical Research NetworkU10HL074206 · NHLBI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI William J Calhoun · fiscal years 2003 to 2008
- Innovative Investigations and Therapies for AsthmaU10HL074073 · NHLBI · NATIONAL JEWISH HEALTH · PI RICHARD J MARTIN · fiscal years 2003 to 2007
- Informative Clinical Studies in AsthmaU10HL074227 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Elliot Israel · fiscal years 2003 to 2007
- Asthma Clinical Research Network (ACRN)U10HL074225 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Stephen P Peters · fiscal years 2003 to 2007
- Asthma Clinical Research Network Center at UCSFU10HL074204 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Homer A Boushey · fiscal years 2003 to 2007
- ASTHMA CLINICAL RESEARCH NETWORKU10HL074218 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Stephen I Wasserman · fiscal years 2003 to 2012
- Treatment of Severe Persistent AsthmaU10HL074212 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Robert F Lemanske · fiscal years 2003 to 2007
- ACRN Data Coordinating CenterU10HL074231 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Vernon M Chinchilli · fiscal years 2003 to 2007
- ROLE OF NITRIC OXIDE AND INTERLEUKIN 1P50HL056419 · NHLBI · WASHINGTON UNIVERSITY · PI WILLIAM E GOLDMAN · fiscal years 1996 to 2005Named on NCT00217854
- ASTHMA CLINICAL RESEARCH NETWORK CENTERU10HL051823 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Homer A Boushey · fiscal years 1993 to 2002Named on NCT00000577
- ASTHMA CLINICAL RESEARCH NETWORKU10HL051831 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Elliot Israel · fiscal years 1993 to 2002Named on NCT00000577
- ASTHMA CLINICAL RESEARCH NETWORK (ACRN)U10HL051834 · NHLBI · NATIONAL JEWISH HEALTH · PI RICHARD J MARTIN · fiscal years 1993 to 2002Named on NCT00000577
- ASTHMA CLINICAL RESEARCH NETWORKU10HL051843 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Robert F Lemanske · fiscal years 1993 to 2002Named on NCT00000577
- ASTHMA CLINICAL RESEARCH NETWORKU10HL051845 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Vernon M Chinchilli · fiscal years 1993 to 2002Named on NCT00000577
- ASTHMA CLINICAL RESEARCH NETWORKU10HL056443 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Emily DIMANGO · fiscal years 1996 to 2002Named on NCT00000577
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:38 UTC. The ranking covers the 200 most relevant of 248 PubMed records, and a shared surname and initials can bring in a namesake. All 248 on PubMed
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.N Engl J Med · 20181,612 citationsRCR 74.0
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.N Engl J Med · 2018937 citationsRCR 42.8
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.Lancet Respir Med · 2015900 citationsRCR 33.1
- 734 citationsRCR 29.0
- Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study.Am J Respir Crit Care Med · 2011563 citationsRCR 16.4
- Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial.Am J Respir Crit Care Med · 2010539 citationsRCR 16.7
- Tiotropium bromide step-up therapy for adults with uncontrolled asthma.N Engl J Med · 2010412 citationsRCR 12.8
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.Lancet Respir Med · 2014387 citationsRCR 13.0
- Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Am J Respir Crit Care Med · 2017363 citationsRCR 17.4
- Influence of complete spinal cord injury on skeletal muscle cross-sectional area within the first 6 months of injury.Eur J Appl Physiol Occup Physiol · 1999309 citationsRCR 10.6